QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Krystal Biotech (KRYS) Earnings Date, Estimates & Call Transcripts

$163.08
-7.07 (-4.16%)
(As of 02/28/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 26)
$0.30 Beat By $0.82
Consensus EPS
(Feb. 26)
-$0.52
Skip Charts & View Estimated and Actual Earnings Data

KRYS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KRYS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Krystal Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.04)($0.04)($0.04)
Q2 20242$0.10$0.11$0.11
Q3 20242$0.17$0.41$0.29
Q4 20242$0.04$0.37$0.21
FY 20247$0.27$0.85$0.56
Q1 20251$0.72$0.72$0.72
Q2 20251$0.87$0.87$0.87
Q3 20251$1.18$1.18$1.18
Q4 20251$0.92$0.92$0.92
FY 20254$3.69$3.69$3.69

KRYS Earnings Date and Information

Krystal Biotech last released its earnings data on February 26th, 2024. The reported $0.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.52) by $0.82. The firm earned $42.14 million during the quarter, compared to analysts' expectations of $27.43 million. Krystal Biotech has generated $0.08 earnings per share over the last year ($0.08 diluted earnings per share) and currently has a price-to-earnings ratio of 2,038.8. Earnings for Krystal Biotech are expected to grow in the coming year, from ($0.50) to $2.63 per share. Krystal Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Krystal Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
2/26/2024Q4 2023($0.52)$0.30+$0.82$0.30$27.43 million$42.14 million      
11/6/2023Q3 2023($1.10)$2.79+$3.89($4.13)$6.29 million$8.60 million      
8/7/2023Q2 2023($1.27)($1.25)+$0.02($1.25)--
5/8/2023Q1 2023($1.41)($1.76)($0.35)($1.76)--
2/27/2023Q4 2022($1.26)($1.25)+$0.01($1.25)--
11/7/2022Q3 2022($1.23)($1.17)+$0.06($1.17)--
8/8/2022Q2 2022($1.08)($1.10)($0.02)($1.10)--
5/9/2022Q1 2022($0.96)($0.99)($0.03)$0.01--
2/28/2022Q4 2021($0.76)($0.94)($0.18)($0.94)--    
11/7/2021Q3 2021($0.76)($0.70)+$0.06($0.70)--
8/8/2021Q2 2021($0.76)($0.74)+$0.02($0.74)--
5/9/2021Q1 2021($0.62)($0.74)($0.12)($0.74)--  
2/28/2021Q4 2020($0.61)($0.53)+$0.08($0.53)--












Krystal Biotech Earnings - Frequently Asked Questions

When is Krystal Biotech's earnings date?

Krystal Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on KRYS's earnings history.

Did Krystal Biotech beat their earnings estimates last quarter?

In the previous quarter, Krystal Biotech (NASDAQ:KRYS) reported $0.30 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.82. Learn more on analysts' earnings estimate vs. KRYS's actual earnings.

How can I listen to Krystal Biotech's earnings conference call?

The conference call for Krystal Biotech's latest earnings report can be listened to online. Listen to Conference Call

How can I read Krystal Biotech's conference call transcript?

The conference call transcript for Krystal Biotech's latest earnings report can be read online. Read Transcript

How can I view Krystal Biotech's earnings report?

Krystal Biotech's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Krystal Biotech generate each year?

Krystal Biotech (NASDAQ:KRYS) has a recorded annual revenue of $50.70 million.

How much profit does Krystal Biotech generate each year?

Krystal Biotech (NASDAQ:KRYS) has a recorded net income of -$139.98 million. KRYS has generated $0.08 earnings per share over the last four quarters.

What is Krystal Biotech's price-to-earnings ratio?

Krystal Biotech (NASDAQ:KRYS) has a trailing price-to-earnings ratio of 2,038.75.

What is Krystal Biotech's EPS forecast for next year?

Krystal Biotech's earnings are expected to grow from ($0.50) per share to $2.63 per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:KRYS) was last updated on 2/28/2024 by MarketBeat.com Staff